Article Versions Notes

Cusano E, Wong C, Taguedong E, Vaska M, Abedin T, Nixon N, Karim S, Tang P, Heng DYC, Ezeife D. Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies. Current Oncology. 2021; 28(6):4894-4928. https://doi.org/10.3390/curroncol28060412

Cusano, Ellen, Chelsea Wong, Eddy Taguedong, Marcus Vaska, Tasnima Abedin, Nancy Nixon, Safiya Karim, Patricia Tang, Daniel Y. C. Heng, and Doreen Ezeife. 2021. "Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies" Current Oncology 28, no. 6: 4894-4928. https://doi.org/10.3390/curroncol28060412

Cusano, E., Wong, C., Taguedong, E., Vaska, M., Abedin, T., Nixon, N., Karim, S., Tang, P., Heng, D. Y. C., & Ezeife, D. (2021). Impact of Value Frameworks on the Magnitude of Clinical Benefit: Evaluating a Decade of Randomized Trials for Systemic Therapy in Solid Malignancies. Current Oncology, 28(6), 4894-4928. https://doi.org/10.3390/curroncol28060412